APR 22, 2017 1:59 PM PDT

Bacteria-infecting Viruses Inspire Creation of Hybrid Antibodies

WRITTEN BY: Kara Marker

It seems humans share a common enemy with some viruses: bacteria. Viruses invade bacterial cells with generally the same agenda that bacteria have when invading the human body - wipe out host cells and multiply. Borrowing a page from the playbook of bacteria-infecting viruses, called bacteriophages, could help researchers enhance the human immune system to better attack the toughest bacterial species.

Summoned by lysibody molecules, large immune cells called macrophages (red) engulf Staphylococcus aureus bacteria (green).

Bacteriophages have unique molecules that recognize and target specific carbohydrate molecules on the cell surface of bacteria, but the human immune system is ignorant of these molecules. “We have co-opted these molecules, and we've put them to work helping the human immune system fight off microbial pathogens," explained lab head Vincent A. Fischetti.

These viruses then use lysins, dubbed “molecular snippers” by Fischetti and his team, to poke holes in the cell surface of the bacterium after latching on to cell surface carbohydrate molecules. Antibodies produced by the human immune system are similar in structure and practice a similar method, but alas they are unable to identify bacterial carbohydrate molecules.

"Both antibodies and lysins have two discrete components,” explained research associate Assaf Raz. “They both have a part that binds their respective target, but whereas the second component of lysins cuts the bacterial cell wall, in antibodies it coordinates an immune response.”

In their study, researchers replaced the parts of human antibodies where their anti-bacterial approach fell short with the advantages of lysins, a switch made possible thanks to the two components sharing similar structure.

"This made it possible for us to mix and match, combining the viral piece responsible for latching onto a carbohydrate with the part of the antibody that tells immune cells how to respond,” Raz said.

The new “best of both worlds” antibody they created was labeled a lysibody, and the researchers ventured next to test lysibodies in a mice model of methicillin-resistant Staphylococcus aureus, commonly known as MRSA, a bacterial species infamous for being resistant to the harshest antibiotic treatments, earning the name of “superbug.”

The mice studies were successful; the experimental lysibodies identified and targeted carbohydrates on the cell surface of MRSA bacteria as well as other strains of S. aureus and even other types of bacteria.

“Based on our results, it may be possible to use not just lysins, but any molecule with a high affinity toward a target on any pathogen -- be it virus, parasite, or fungus -- to create hybrid antibodies," Fischetti claimed. "This approach could make it possible to develop a new class of immune boosting therapies for infectious diseases."

The present study was published in the journal Proceedings for the National Academy of Sciences.

Source: The Rockefeller University

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
FEB 14, 2020
Immunology
FEB 14, 2020
Rewired natural killer cells show promising results in leukemia patients
Natural killer (NK) cells are a subset of white blood cells that are key players in the innate immune system, orchestrat ...
MAR 02, 2020
Drug Discovery & Development
MAR 02, 2020
DIY Fecal Transplants Improve Symptoms in 82% of People
Fecal transplants (FMT), the process of putting a healthy person’s fecal matter into another person’s colon, ...
MAR 03, 2020
Clinical & Molecular DX
MAR 03, 2020
Singapore charges ahead with antibody-based test for COVID-19
Researchers, biotech and pharmaceutical companies are scrambling to put an end to the coronavirus disease (COVID-19) out ...
APR 21, 2020
Cancer
APR 21, 2020
Scientists develop tumor immunity map
A new study published in eLife describes the findings from a study that has successfully mapped tumor cell molecule ...
MAY 05, 2020
Immunology
MAY 05, 2020
Winter the Llama: An Unlikely Hero in the Fight Against COVID-19
A new hero in the fight against COVID-19 has emerged: 4-year-old Winter, a llama that currently resides in the Belgian c ...
MAY 17, 2020
Genetics & Genomics
MAY 17, 2020
How Non-Coding Genomic Regions Influence Autoimmune Disease
Scientists have gained new insight into autoimmune and allergic disorders.
Loading Comments...